BRAF, NRAS, or NF1 mutations can co-occur with C/T mutations in the promoter region of the telomerase reverse transcriptase (TERT) gene, which are frequently observed in melanoma, occurring in 30–85% of cases depending on disease stage. This evidence concerns the gene NRAS and melanoma.